MedTrace Logo

Pregnancy Monitoring Using Mobile Application

NCT05741931 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 216

Last updated 2023-02-23

No results posted yet for this study

Summary

The goal of this Randomized Controlled Trial is to compare the health condition of pregnant women through pregnancy monitoring in the implementation of pregnancy class. The main question it aims to answer are:

How is the condition of the mother and baby after pregnancy monitoring using the REST mobile application (Risk identification, Evaluation counseling, Systematic monitoring, Trobleshooting)

Participants will be monitored for the condition of their pregnancy from 20 weeks of pregnancy until delivery. Participants will attend in the pregnancy class as many as 3 meetings and a pregnancy check-up by the midwife.

Researchers will compare intervention group to see if normal delivery methods, birth weight of the baby (\>2500), antenatal care visits (\>6 times), and prevention of pregnancy complications were better than the control group.

Conditions

  • Maternal and Child Health

Interventions

DEVICE

mobile application REST (Risk identification, Evaluation counseling, Systematic monitoring, Troubleshooting)

The mobile application will be installed on the mobile phone. The application is used to monitor pregnant women. Users of the application are midwives and pregnant women. The application contains documentation of the health condition of pregnant women.

Sponsors & Collaborators

  • Gadjah Mada University

    lead OTHER

Principal Investigators

  • Prima D Ratrikaningtyas · Gadjah Mada University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-08-31
Primary Completion
2024-08-31
Completion
2024-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05741931 on ClinicalTrials.gov